Acute and 90-day subchronic toxicity studies of silk peptide e5k6, in sprague-dawley rats

Food and Chemical Toxicology

Volumn 49, Issue 9, 2011, Pages 2408-2414

  Han, Zhong Ze ^a   Koo, Kyo Hwan ^a   Kim, Kwang Ho ^a   Bae, Jin Sook ^a   Shin, Seo Ho ^a   Kim, Hak Soo ^a   Kim, Ji Hoon ^a   Heo, Hyun Suk ^a   Gil, Ki Hyun ^a   Lee, Joo Young ^a   Kim, Kap Ho ^a   Kang, Boo Hyon ^a   Lee, Hyun Kul ^a   Choi, Ho Young ^a   Li, Yong Chun ^a   Yeon, Seong Ho ^b   Lee, Jeong Yong ^b   Song, Si Whan ^a  

^a Chemon Inc   (South Korea)

^b WORLDWAY Co Ltd   (South Korea)

Author keywords

90 Day subchronic oral toxicity; Acute oral toxicity; Silk peptide E5K6; Sprague Dawley rats

Indexed keywords

CREATINE KINASE; PROTEIN HYDROLYSATE; SILK PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD EXAMINATION; BODY WEIGHT; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; FLUID INTAKE; FOOD INTAKE; HISTOPATHOLOGY; MALE; MORTALITY; NONHUMAN; ORGAN SIZE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SPRAGUE DAWLEY RAT; TOXICITY TESTING; URINALYSIS; URINE PH;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INSECT PROTEINS; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SILK;

ANIMALIA; RATTUS;

EID: 79960842241     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.058     Document Type: Article

References (35)

1. Akai H. New physiological functions of silk material. Shokuhin Kaihatsu 1999, 34:45-47.
2. Aramwit P., Sangcakul A. The effects of sericin cream on wound healing in rats. Biosci. Biotechnol. Biochem. 2007, 71:2473-2477.
3. Aramwit P., Damrongsakkul S., Kanokpanont S., Srichana T. Properties and antityrosinase activity of sericin from various extraction methods. Biotechnol. Appl. Biochem. 2010, 55:91-98.
4. Boorman G.A., Eustis S.L., Elwell M.R., Montgomery C.A., Mackenzie W.F. Pathology of the Fischer Rat 1990, Academic Press, San Diego.
5. Byun E.B., Sung N.Y., Kwon S.K., Song B.S., Kim J.H., Choi J.i., Hwang H.J., Byun M.W., Lee J.W. In vitro and in vivo studies on the cytotoxicity of irradiated silk fibroin against mouse melanoma tumor cell. Radiat. Phys. Chem. 2009, 78:429-431.
6. Gotoh K., Izumi H., Kanamoto T., Tamada Y., Nakashima H. Sulfate fibroin, a novel sulfated peptide derived from silk, inhibits human immunodeficiency virus replication in vitro. Biosci. Biotechnol. Biochem. 2000, 64:1664-1670.
7. Greaves P. Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation 2000, Elsevier, Amsterdam. second ed.
8. Haller C.A., Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N. Engl. J. Med. 2000, 343:1833-1838.
9. Han Z.Z., Xu H.D., Kim K.H., Ahn T.H., Bae J.S., Lee J.Y., Gil K.H., Lee J.Y., Woo S.J., Yoo H.J., Lee H.K., Kim K.H., Park C.K., Zhang H.S., Song S.W. Reference data of the main physiological parameters in control Sprague-Dawley rats from pre-clinical toxicity studies. Korean J. Lab. Anim. Sci. 2010, 26:153-164.
10. Hard G.C. Species composition of the content and composition of urinary proteins. Food Chem. Toxicol. 1995, 33:731-746.
11. Hong S.E., Park K.J., Suh B.S., Do M.S., Hyun C.K. Effect of silk fibroin hydrolysate on adipocyte metabolism in db/db mice. Korean J. Pharmacogn. 2002, 33:312-318.
12. Hyun J.W., Lee K.G., Yeo J.H., Choe T.B. Hair care effects of hair cosmetics including low molecular weight silk peptide component and micro structure analysis. Korean J. Biotechnol. Bioeng. 2008, 23:439-444.
13. Jakkula M., Boucher T.A., Beyendorff U., Conn S.M., Johnson J.E., Nolan C.J., Peine C.J., Albrecht J.H. A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C. Arch. Intern. Med. 2004, 164:1341-1346.
14. Jung E.Y., Lee H.S., Lee H.J., Kim J.M., Lee K.W., Suh H.J. Feeding silk protein hydrolysates to C57BL/KsJ-db/db mice improves blood glucose and lipid profiles. Nutr. Res. 2010, 30:783-790.
15. Kato N., Sato S., Yamanaka A., Yamada H., Fuwa N., Nomura M. Silk protein, sericin, inhibits lipid peroxidation and tyrosinase activity. Biosci. Biotechnol. Biochem. 1998, 62:145-147.
16. KFDA, 2009a. Good Laboratory Practice Regulation for Non-Clinical Laboratory Studies (Notification No. 2009-102). KFDA, Korea.
17. KFDA, 2009b. The Standards of Toxicity Study for Medicinal Products (Notification No. 2009-116). KFDA, Korea.
18. Lehman-McKemman L.D., Caudill D. Quantitation of a2U-globulin and albumin by reverse-phase high performance liquid chromatography. J. Pharmacol. Methods 1991, 26:239-247.
19. Mita K., Ichimura S., Tharappel C.J. Highly repetitive structure and its organization of the silk fibroin gene. J. Mol. Evol. 1994, 38:583-592.
20. Mohr U., Dungworth D.L., Capen C.C. Pathobiology of the Aging Rat 1992, International Life Sciences Institute, Washington DC, pp. 161-172.
21. Nahm J.H., Oh Y.S. A study of pharmacological effect of silk fibroin. RDA J. Agric. Sci. 1995, 37:145-157.
22. OECD, 1998 a. OECD Principles of Good Laboratory Practice ENV/MC/CHEM (98) 17. OECD, Paris.
23. OECD, 1998b. Guidelines for Testing of Chemicals. Guideline 408. Repeated Dose 90-day Oral Toxicity Study in Rodents. OECD, Paris.
24. Palmer M.E., Haller C., McKinney P.E., Klein-Schwartz W., Tschirgi A., Smolinske S.C., Woolf A., Sprague B.M., Ko R., Everson G., Nelson L.S., Dodd-Butera T., Bartlett W.D., Landzberg B.R. Adverse events associated with dietary supplements: an observational study. Lancet 2003, 361:101-106.
25. Pittler M.H., Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment. Pharmacol. Ther. 2003, 18:451-471.
26. Ryu J.M., Kim T.M., Seo I.K., Yeon S., Lim W.T., Lee J.Y., Hwang S.Y., O N.G., Song J., Lee J., Kim Y.B. Effect of repeated administration of silk peptide on the immune system of rats. Lab. Anim. Res. 2008, 24:361-369.
27. Subhas C.K., Biraja C.D., Dash R., Kaplan D.L. Natural protective glue protein, sericin bioengineered by silkworms: potential for biomedical and biotechnological applications. Prog. Polym. Sci. 2008, 33:998-1012.
28. Sugiyama K., Kushima Y., Muramatsu K. Effect of sulfur containing amino acid and glycine on plasma cholesterol level in rats fed on a high cholesterol diet. Agric. Biol. Chem. 1985, 49:3455-3461.
29. Suzuki N., Fuzimura A., Nagai T., Mizumoto I., Itami T., Hatate H., Nozawa T., Kato N., Nomoto T., Yoda B. Antioxidative activity of animal and vegetable dietary fibers. BioFactors 2004, 21:329-333.
30. Tannehill-Gregg S.H., Dominick M.A., Reisinger A.J., Moehlenkamp J.D., Waites C.R., Stock D.A., Sanderson T.P., Cohen S.M., Arnold L.L., Schilling B.E. Strain-related differences in urine composition of male rats of potential relevance to urolithiasis. Toxicol. Pathol. 2009, 37:293-305.
31. World Health Organization WHO traditional medicine strategy 2002-2005 2002, WHO, Geneva.
32. Wu J.H., Wang Z., Xu S.Y. Preparation and characterization of sericin powder extracted from silk industry wastewater. Food Chem. 2007, 103:1255-1262.
33. Yang Y.N., Tang L.M., Tong L., Liu H. Silkworms culture as a source of protein for humans in space. Adv. Space Res. 2009, 43:1236-1242.
34. Zhang Y. Study on new approach of silk fibroin utilization. Chin. Bull. Entomol. 1995, 32:254-255. (in Chinese).
35. Zhaorigetu S., Yanaka N., Sasaki M., Watanabe H., Kato N. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J. Photochem. Photobiol. B. 2003, 71:11-17.